Penyelidikan & Penerbitan

Kajian klinikal menggunakan sel stem mesenkimal untuk Covid-19.

Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia

Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells

Dipelopori oleh para pakar sel punca kami, group CryoCord telah berkecimpung di banyak riset dan publikasi selama bertahun-tahun. Berikut ini adalah publikasi atas riset yang dilakukan oleh para pakar kami dan mitranya.

MOK (2003) Isolation and identification of putative MSC rom BM

Choong (2007) Generating neuron-like cells from BMMSC in vitro

Choong (2007) MSC-like characteristics of corneal keratocytes

Mok (2008) In-vitro differentiation study on isolated MSC

Wong (2008) Differentiation of hMSC into mesangial cells in post-glomerular injury murine model

Mok (2009) In vitro expression of erythropoietin by transfected hMSC

Chin (2010) Cryopreserved MSC for severe dilated ischemic cardiomyopathy

Chin (2011) Intramyocardial and intracoronary MSC treatment in chronic severe DCM